The New York Times reported, “Growing evidence suggeststhat the method by which blood sugar is lowered may make a big difference in heart risk” in people with type 2 diabetes [T2D]. What’s more, “it’s becoming clear, researchers say, that there’s far too little evidence on how diabetes drugs affect the heart to make rational evidence-based judgments.” This has now “raised a medical dilemma affecting tens of millions of people with type 2 diabetes – and for the doctors who treat them.”